personalized medicine Archives
Nov. 18, 2019— by Bill Snyder Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, has been awarded the 2019 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences by The Ohio State University Wexner Medical Center’s Heart and Vascular Center, Ohio State officials announced Nov. 18. Awarded biennially, the Schottenstein Prize honors...
Nov. 14, 2019—VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.
Oct. 24, 2019—Genotyping can improve outcomes in patients who require anti-platelet therapy following stent placement to open narrowed or blocked coronary arteries and prevent a heart attack.
Oct. 17, 2019—Josh Peterson, MD, MPH, and Dan Roden, MD, are among 10 leaders in clinical pharmacology and translational medicine recognized this week by the American Society for Clinical Pharmacology and Therapeutics.
Oct. 3, 2019—Rapid blood culture diagnostics for patients with bacterial bloodstream infections delivered final results in 12 hours versus the two to three days required for conventional testing.
May. 9, 2019—The national “All of Us” Research Program, which aims to accelerate the prevention and treatment of illness by recruiting a million or more research participants, provided a glimpse this week into its rapidly growing databank with the beta launch of its publicly accessible Data Browser application.
Feb. 7, 2019—Some biomedical researchers may be unsure about routine electronic health record (EHR) data and how useful it ultimately may prove for drawing meaningful, actionable associations that warrant changes to clinical practice and lead to improved clinical outcomes.
Aug. 2, 2018—During the August Leadership Assembly at Vanderbilt University Medical Center, patients whose lives have been restored through personalized care shared their emotional stories, illustrating the Medical Center’s longtime commitment to use the latest advancements in genomic medicine as a powerful tool to tailor care to the individual.
Jun. 21, 2018—Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.
Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.